The first approved COVID-19 drug is far from 'amazing'

The first approved COVID-19 drug is far from 'amazing'
Hollis Johnson/Business Insider

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.

Hello,

The coronavirus pandemic is overwhelming the US yet again, with the country recording its 2 worst-ever days of infection over the weekend.
Advertisement
"We are not going to control the pandemic," White House Chief of Staff Mark Meadows said Sunday on CNN.

Also in healthcare news: Gilead's set to make billions on a drug that's far from "amazing", AstraZeneca and Johnson & Johnson have restarted vaccine trials in the US, and universal masking could save 130,000.

78874406

Gilead is set to sell billions of dollars of a coronavirus drug that's far from 'amazing' after the US approved remdesivir to treat COVID-19

Read the full story from Andrew Dunn here>>
Advertisement

78874412

AstraZeneca and Johnson & Johnson get FDA green light to resume coronavirus vaccine trials in the US after participants got sick

Read the full story from Allana Akhtar here>>

78874421

Universal mask-wearing could save 130,000 US lives before March, mitigating the worst of this 3rd coronavirus surge

Read the full story from Aria Bendix here>>
Advertisement

More stories we're reading:

Subscribe here for daily updates from the healthcare team!

- Lydia
Advertisement
{{}}